Managing Distributor Compliance In China Needs A Systematic Approach, Says Stryker China GM
This article was originally published in PharmAsia News
China is tightening oversight of multinationals’ commercial practices, particularly for third-party vendors and distributors. Distributors are necessary to cover a vast country like China, but they can be managed to be in full compliance, says Stryker Corp.’s China GM.
You may also be interested in...
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.
As China is poised to supply medical products to fight the coronavirus around the world, a battle to banish its image of poor product quality is on.
China insurance giant snatches up stakes in Japanese pharma and a traditional Chinese medicines maker with a $465m spending spree.